Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Decommissioning and Disposal of Existing Linear Accelerator

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract entails the safe decommissioning, removal, and environmentally compliant disposal of a TrueBeam STX linear accelerator with serial number H192104, located at the National Institutes of Health NIAID facility in Bethesda, Maryland. The scope includes complete data sanitization to ensure no protected health or operational information remains, followed by thorough site restoration to return the area to its original condition. All activities must adhere to federal, state, and local environmental regulations, with particular attention to handling hazardous materials and radioactive components associated with the equipment. The work must be performed by qualified personnel with demonstrated expertise in medical linear accelerator decommissioning and waste management. The solicitation is issued as a subcontract under the NAICS code 562910, which pertains to remediation services, and is managed by the Department of Health and Human Services through its National Institute of Allergy and Infectious Diseases. The opportunity was posted on July 24, 2026, with a response deadline of August 2, 2026. Proposals must demonstrate capability in handling sensitive medical radiation devices, proper documentation of disposal procedures, and compliance with all regulatory standards for radiation safety and environmental protection. The successful contractor will be responsible for coordinating all logistics, permits, and certifications required for the decommissioning process and ensuring full accountability from removal through final disposal.

General Info

Decommission and dispose of TrueBeam STX accelerator H192104 at NIH NIAID with regulatory compliance and site restoration.

Agency

Department Of Health And Human Services → National Institutes Of Health NiaidView Agency

NAICS

562910 - Remediation ServicesView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Niaid
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Safe removal, decommissioning, and environmentally compliant disposal of TrueBeam STX (H192104), including data sanitization and site restoration.

Similar Contracts

Same NAICS industry code

NAICS: 562910
New
SLED
Lead Hazard Reduction & Healthy Homes Intervention 128 Franklin ST, Waterbury, CTThe City of Waterbury is soliciting sealed bids for Lead Hazard Reduction and Healthy Homes Intervention services at 128 Franklin Street, Waterbury, Connecticut, under Bid Number 8894. The bid opening is scheduled for August 12, 2026, at 10:30 AM, with all submissions required to be received by that time and no late bids accepted. Bids must be submitted in accordance with the Invitation to Bid and will be publicly opened at the Director of Purchasing’s office. Attendance at the mandatory pre-bid conference on August 3, 2026, at 10:00 AM at the project site is required for any party wishing to submit a proposal, and sign-in at the event is necessary to remain eligible. The clarification deadline for questions is August 5, 2026, at 2:00 PM, and all bids must comply with the specifications outlined in the solicitation. The contract falls under NAICS Code 562910 and is classified as a state and local government procurement. The procurement is administered by the City of Waterbury in Connecticut, with the primary point of contact being mmccauley@waterburyct.org for inquiries. The bid is being processed offline and is open for bidding in USD, with no set-aside type indicated. Bidders must register to access bid-related documents and must adhere strictly to procedural deadlines, including the pre-bid conference attendance requirement, as failure to comply will disqualify participation. The project aims to address lead hazards and promote healthy living conditions in the specified residential property.
City of Waterbury

POSTED

1 day ago

DEADLINE

in 17 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 334510
New
Federal
Supply and Installation of TrueBeam Edge Linear Accelerator SystemThe contract entails the supply, delivery, installation, and commissioning of a TrueBeam Edge Linear Accelerator system equipped with an HD120 MLC, RapidArc technology, and an IGRT Couch Top, fully integrated with the ARIA OIS and Eclipse TPS for comprehensive radiotherapy management. This advanced radiation therapy system is designed to deliver precise, high-efficiency treatments with enhanced image-guided capabilities, ensuring optimal patient outcomes through automated workflows and conformal dose delivery. The equipment will be installed and commissioned at the designated facility in Bethesda, Maryland, with all components required to meet strict clinical and technical specifications for oncology treatment delivery. The contract is classified as a subcontract under NAICS code 334510, issued by the National Institutes of Health, National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services. The solicitation was posted on July 24, 2026, with a response deadline of August 2, 2026. Performance is specified to occur at the Bethesda location, which serves as the primary site for clinical operations. All activities including system integration, testing, and validation must align with regulatory and operational standards to ensure immediate clinical readiness upon commissioning.
Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

1 day ago

DEADLINE

in 8 days
View Details
NAICS: 334516
New
Federal
Replacement of TrueBeam STX H192104The National Institute of Allergy and Infectious Diseases (NIAID) is seeking a replacement for its existing Varian TrueBeam STX linear accelerator (H192104), which has been in service since 2014 and is nearing the end of its operational life. The acquisition, issued as a Request for Quotes under Simplified Acquisition Procedures, calls for a new Varian TrueBeam Edge Radiotherapy Accelerator with identical performance specifications and configurations to ensure seamless integration and continuity of patient care. The new system must match the capabilities of the current unit, including support for advanced treatment techniques such as TrueBeam Upgrade H193045, HyperArc, HyperSight, RapidArc, IMRT, and Total Body irradiation, and must be compatible with existing ARIA and Eclipse software versions. All interfaces with the NIH Hospital Information System must remain fully operational, including remote monitoring via HL7-compliant SSL-VPN-TLS connections and integration with the NIH Active Directory. The vendor is required to uninstall and dispose of the existing equipment, ship the new system FOB destination to 10 Center Dr, Bethesda, MD 20892, and maintain the same radiation isocenter position, power, cooling, and electrical infrastructure. Technical compliance is the primary evaluation factor, followed by price, with award anticipated to the lowest technically acceptable offer under a firm-fixed-price contract. The solicitation requires the vendor to be FDA-certified, with qualified engineers and OEM-approved components, and to provide all mandatory software updates. The system must include an HD120 High Definition MLC with dual independent jaws, dual kV and MV imaging systems with automated 2D/3D image matching, online physician approval at the treatment console, and the ability to generate custom DRR templates within Eclipse. Additional requirements include electronic dynamic wedges, unplanned treatment mode up to five fractions, automated machine performance checks, and access to a marketing kit for public outreach. The vendor must be registered in the System for Award Management (SAM), complete all commercial item representations and certifications, and comply with federal provisions including prohibitions on inverted domestic corporations and restricted telecommunications equipment. Submissions must be received by August 2, 2026, at 4:00 PM EST, emailed to Jessica Emerson with the RFQ number in the subject line, and must include full compliance with all FAR and HHSAR clauses listed. Only responsible sources may respond, and no set-aside provisions apply; the procurement is open
Analytical Laboratory Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 8 days
View Details
NAICS: 541715
New
Federal
Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB)The solicitation BAA-75N93026R00008, titled Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB), is a Broad Agency Announcement issued by the National Institutes of Health, National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services. The goal is to renew and expand a center focused on accelerating tuberculosis vaccine development by deeply characterizing protective immune responses to Mtb, particularly in the context of HIV/SIV coinfection. Proposals must integrate human samples or clinical studies, at least one animal model, and computational modeling platforms to identify immune signatures linked to protection or disease risk, evaluate protective antigens and epitopes, and refine tissue-specific and cross-species models including novel approaches like organoids and ex vivo systems. The contract is structured as a cost reimbursement, completion type with an anticipated performance start date of September 1, 2027, and a maximum funding period of five years. Individual awards are estimated to total approximately $5 million per year, with the overall program budget averaging $10.5 million annually across two to three awarded contracts. Each contractor must reserve $300,000 per year from years two through five specifically for cross-contract collaborative studies, which cannot be proposed in the initial submission but will be developed and selected jointly by NIH program staff, the principal investigators, and the External Scientific Advisory Group, with final approval by NIH. Proposals must be submitted electronically through the NIAID electronic Contract Proposal Submission system by the deadline of September 1, 2026; submissions by email, fax, or collect calls are strictly prohibited. The NAICS code for this procurement is 541715, and all correspondence should be directed to the designated points of contact at the Bethesda, Maryland office.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
Federal
RADIOLOGICAL OR NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT (PDS)The solicitation 75N93026R00005 seeks support for the development of medical countermeasures against radiological and nuclear threats, specifically targeting advancement toward FDA approval or licensure for acute radiation syndrome and delayed effects of acute radiation exposure. This is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract anticipated to be awarded for a seven-year period beginning on or about July 1, 2027, with no options included in the base contract, although individual task orders may carry term and quantity options. The work will involve a broad range of activities from early research through post-marketing support, including administrative and technical support, development and testing of animal models and new approach methodologies, non-clinical studies for IND/NDA/BLA submissions, chemistry, manufacturing and control support, and Phase I clinical studies. The contractor must possess and demonstrate compliance with Good Laboratory Practice, current Good Manufacturing Practice, and Good Clinical Practice standards, along with adequate scientific and technical personnel, facilities, equipment, and project management capabilities. Collaboration with the National Institute of Allergy and Infectious Diseases, the Food and Drug Administration, and other organizations with existing medical countermeasures is required. Evaluation of proposals will focus on the technical approach and methodology, organizational experience in developing medical countermeasures against radiological and nuclear agents, and the adequacy of personnel, facilities, and compliance systems. Proposals must be submitted online through the NIAID electronic Contract Proposal Submission website by August 31, 2026; submissions via email or fax are prohibited. The solicitation is not set aside for any socioeconomic category and falls under NAICS code 541715, with the National Institutes of Health, through NIAID, serving as the procuring agency based in Bethesda, Maryland. Point of contact for questions includes Karen Telphia and Robert Corno, and the full solicitation is available on SAM.gov.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

in about 1 month
View Details